Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors
Review article: alginate-raft formulations in the treatment of heartburn and acid reflux
A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects
Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection
Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole
A new highly effective short-term therapy schedule for Helicobacter pylori eradication
The effectiveness of omeprazole, clarithromycin and tinidazole in eradicating Helicobacter pylori in a community screen and treat programme
High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis
Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens
Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study
Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori
Cyclosporin in the treatment of adults with refractory coeliac disease—an open pilot study
Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers
Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function
The effects of meloxicam, indomethacin or NS-398 on eicosanoid synthesis by fresh human gastric mucosa
Open label trial of oral clarithromycin in active Crohn’s disease
Ridogrel, a dual thromboxane synthase inhibitor and receptor antagonist: anti-inflammatory profile in inflammatory bowel disease
The effects of smoking and indomethacin on small intestinal permeability
Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract
Botulinum toxin injected in the gastric wall reduces body weight and food intake in rats
Systemic effect of peanut agglutinin following intravenous infusion into rats
Tepoxalin inhibits inflammation and microvascular dysfunction induced by abdominal irradiation in rats